Endoglin expression is also upregulated in several cancers (Pérez-Gómez et al., 2010), including melanoma (Pardali et al., 2011), ovarian cancer (Steg et al., 2012), breast cancer (Davidson et al., 2010), and gastric cancer (Miao et al., 2016). Here, ENG is linked to breast carcinoma.